Variables | Ovarian stimulation protocol | p value | ||
---|---|---|---|---|
PPOS | GnRH agonist | GnRH antagonist | ||
Patients (n) | 58 | 88 | 130 | |
Endometrial preparation, (%)* | ||||
Natural cycles | 8.62%(5/58) | 38.64%(34/88) | 20%(26/130) | 0000a,c |
Clomid-induced | 17.24%(10/58) | 9.09%(8/88) | 7.69%(10/130) | 0.124 |
Hormonal cycles | 75.86%(44/58) | 52.27%(46/88) | 72.31%(94/130) | 0.002a,c |
Endometrial thickness (mm) | 9.6(8.63–10.6) | 8(8–9.75) | 9(8–10) | 0.001a |
Biochemical pregnancy rate per transfer (%)* | 70.69%(41/58) | 60.23%(53/88) | 60.77%(79/130) | 0.364 |
Clinical pregnancy rate per transfer (%)* | 51.72%(30/58) | 57.95%(51/88) | 56.15%(73/130) | 0.755 |
Implantation rate (%)* | 51.72%(30/58) | 57.95%(51/88) | 56.15%(73/130) | 0.755 |
Ongoing pregnancy rate per transfer (%)* | 46.55%(27/58) | 52.27%(46/88) | 50%(65/130) | 0.795 |
Miscarriage rate (%)* | 7.32%(3/41) | 9.43%(5/53) | 12.66%(10/79) | 0.637 |
Ectopic pregnancy rate (%)* | 4.88%(2/41) | 0.000 | 1.27%(1/79) | 0.181 |
Live birth rate per transfer (%)* | 43.1%(25/58) | 45.45%(40/88) | 39.23%(51/130) | 0.648 |
Cumulative clinical pregnancy rate per woman (%)* | 28.08%(41/146) | 32.5%(52/160) | 26.49%(80/302) | 0.393 |
Cumulative live birth rate per woman (%)* | 20.55%(30/146) | 27.5%(44/160) | 19.21%(58/302) | 0.112 |